FBP1 and type 2 diabetes mellitus: Fructose 1,6-bisphosphatase (FBPase), a highly regulated enzyme that catalyzes the second to last step in gluconeogenesis, draws attention as a potential therapeutic target to treat type 2 diabetes mellitus [10,11].